Aspiriant, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Aspiriant, LLC

$2.61 Billion
Q3 2024

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 04, 2019	SELL	N/A	-2,175 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	N/A	-116 Reduced 5.06%	2,175 $209,000
Q2 2018 Aug 07, 2018	BUY	N/A	2,291 New	2,291 $218,000

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

Goldman Sachs Group Inc New York, NY

12.7M
Shares

$1.27 Billion
0.21% of portfolio
Jpmorgan Chase & CO New York, NY

12.3M
Shares

$1.22 Billion
0.1% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

9.23M
Shares

$919 Million
2.24% of portfolio
Morgan Stanley New York, NY

8.02M
Shares

$799 Million
0.06% of portfolio
Citigroup Inc

7.75M
Shares

$772 Million
0.45% of portfolio

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.